Cannabinoids: From pot to lab

Esther Papaseit, Clara Pérez-Mañá, Ana Pilar Pérez-Acevedo, Olga Hladun, M. Carmen Torres-Moreno, Robert Muga, Marta Torrens, Magí Farré

Research output: Contribution to journalReview articleResearchpeer-review

36 Citations (Scopus)


© Ivyspring International Publisher. Cannabis is becoming increasingly present in our society. In recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and the medical (pharmaceutical cannabinoids and medical cannabis) has been crossed. In this paper we review some of the novel aspects of cannabis and cannabinoids in relation to their legal situation, changes in their composition and forms of cannabis use, the concept of medical cannabis, and synthetic cannabinoids as new psychoactive substances (NPS). We have also analyzed serious adverse reactions and intoxications associated with the use of synthetic cannabinoids, as well as the latest developments in the research of pharmaceutical cannabinoids.
Original languageEnglish
Pages (from-to)1286-1295
JournalInternational Journal of Medical Sciences
Issue number12
Publication statusPublished - 6 Aug 2018


  • Cannabidiol (CBD)
  • Cannabis
  • Delta-9-tetrahydrocannabinol (THC)
  • Medical cannabis
  • Synthetic cannabinoid


Dive into the research topics of 'Cannabinoids: From pot to lab'. Together they form a unique fingerprint.

Cite this